Biotricity (BTCY)

Overall impact
B (64)

Commentary

Biotricity is a strong overall performer. With a 'B' rating of 64.1 for overall impact (71st percentile compared to all companies), Biotricity ranks 57th out of 103 industry peers, behind Waters, MyMD Pharmaceuticals, Alphatec and 53 others, and ahead of Tandem Diabetes Care, InMode, Envista Holdings and 43 others. On top material causes for Biotricity's industry (Healthcare Equipment), Biotricity performs well in Reduced Waste (88.1 score), Improved Mental Health (80.3), Access to Affordable Healthcare (84.2) and 1 other cause where it received an 'A' score and performs poorly in Technology Innovation (35.4 score) and Reduced Green House Gas Emissions (28.9).
Impact
Cause BTCY
Peer rank
Overall impact

Log in to view this information

Impact trend

Change in rating for overall impact

Log in to view this information

Company
Employees
46
Sector
Health Care
Industry
Health Care Equipment & Supplies
Sub-industry
Health Care Supplies
SASB industry
Medical Equipment & Supplies
Headquarters
Ca, United States
Share classes
BTCY
Description
Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on the delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers the Bioflux mobile cardiac telemetry solution, an integrated ECG device, and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. Biotricity, Inc. is based in Redwood City, California.
Material causes
Ethos considers the following causes material for Biotricity, based on its industry sub-industry Health Care Supplies. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.